Biogen (Mexico) Market Value

BIIB Stock  MXN 3,250  228.71  6.57%   
Biogen's market value is the price at which a share of Biogen trades on a public exchange. It measures the collective expectations of Biogen Inc investors about its performance. Biogen is trading at 3250.00 as of the 29th of November 2024; that is 6.57 percent decrease since the beginning of the trading day. The stock's open price was 3478.71.
With this module, you can estimate the performance of a buy and hold strategy of Biogen Inc and determine expected loss or profit from investing in Biogen over a given investment horizon. Check out Biogen Correlation, Biogen Volatility and Biogen Alpha and Beta module to complement your research on Biogen.
Symbol

Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Biogen 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biogen's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biogen.
0.00
12/10/2022
No Change 0.00  0.0 
In 1 year 11 months and 21 days
11/29/2024
0.00
If you would invest  0.00  in Biogen on December 10, 2022 and sell it all today you would earn a total of 0.00 from holding Biogen Inc or generate 0.0% return on investment in Biogen over 720 days. Biogen is related to or competes with UnitedHealth Group, Genworth Financial, Verizon Communications, Capital One, Grupo Sports, Bank of Nova Scotia, and Costco Wholesale. Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative di... More

Biogen Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biogen's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biogen Inc upside and downside potential and time the market with a certain degree of confidence.

Biogen Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Biogen's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biogen's standard deviation. In reality, there are many statistical measures that can use Biogen historical prices to predict the future Biogen's volatility.
Hype
Prediction
LowEstimatedHigh
3,2483,2503,252
Details
Intrinsic
Valuation
LowRealHigh
3,0203,0223,575
Details
Naive
Forecast
LowNextHigh
3,2573,2593,261
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
3,1433,4453,747
Details

Biogen Inc Backtested Returns

Biogen Inc secures Sharpe Ratio (or Efficiency) of -0.14, which signifies that the company had a -0.14% return per unit of risk over the last 3 months. Biogen Inc exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biogen's Standard Deviation of 2.06, mean deviation of 1.02, and Risk Adjusted Performance of (0.1) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.44, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Biogen are expected to decrease at a much lower rate. During the bear market, Biogen is likely to outperform the market. At this point, Biogen Inc has a negative expected return of -0.3%. Please make sure to confirm Biogen's treynor ratio, potential upside, and the relationship between the total risk alpha and maximum drawdown , to decide if Biogen Inc performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.42  

Average predictability

Biogen Inc has average predictability. Overlapping area represents the amount of predictability between Biogen time series from 10th of December 2022 to 5th of December 2023 and 5th of December 2023 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biogen Inc price movement. The serial correlation of 0.42 indicates that just about 42.0% of current Biogen price fluctuation can be explain by its past prices.
Correlation Coefficient0.42
Spearman Rank Test0.27
Residual Average0.0
Price Variance89.1 K

Biogen Inc lagged returns against current returns

Autocorrelation, which is Biogen stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Biogen's stock expected returns. We can calculate the autocorrelation of Biogen returns to help us make a trade decision. For example, suppose you find that Biogen has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Biogen regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Biogen stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Biogen stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Biogen stock over time.
   Current vs Lagged Prices   
       Timeline  

Biogen Lagged Returns

When evaluating Biogen's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Biogen stock have on its future price. Biogen autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Biogen autocorrelation shows the relationship between Biogen stock current value and its past values and can show if there is a momentum factor associated with investing in Biogen Inc.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Biogen Stock Analysis

When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.